Olfr585, a member of the olfactory receptor family, plays a pivotal role in the intricate process of olfactory signal transduction. Positioned within the olfactory epithelium, Olfr585 functions as a molecular sensor responsible for detecting specific odorants present in the environment. Upon interaction with odorant molecules, Olfr585 initiates a series of intracellular events that ultimately lead to the generation and transmission of olfactory signals. This process is essential for our ability to perceive and distinguish various smells, contributing significantly to the complex and nuanced human sense of smell.
The general mechanisms of inhibiting Olfr585 involve targeting specific signaling pathways associated with its function. The identified inhibitors impact critical pathways such as PI3K/AKT, TGF-β, PPARγ, MAPK, NF-κB, and Rho/ROCK. Through their actions on these pathways, the inhibitors modulate downstream processes crucial for olfactory signal transduction, indirectly inhibiting Olfr585. Understanding and manipulating these intracellular pathways offer insights into the fundamental mechanisms governing olfactory receptor function, contributing to the broader understanding of olfaction at the molecular level. This knowledge not only advances our understanding of olfaction but also provides a foundation for potential applications in research settings where precise modulation of olfactory receptors is desired.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
Akt inhibitor impacting the PI3K/AKT signaling pathway. Its modulation of this pathway indirectly inhibits Olfr585 by disrupting downstream processes crucial for olfactory signal transduction. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β receptor inhibitor affecting the TGF-β signaling pathway. Indirectly inhibits Olfr585 by disrupting the TGF-β cascade, altering cellular processes associated with olfactory signal transduction. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
PPARγ antagonist influencing the PPARγ signaling pathway. Its action on this pathway indirectly inhibits Olfr585, disrupting downstream processes essential for olfactory signal transduction. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AKT kinase inhibitor impacting the PI3K/AKT signaling pathway. Indirectly inhibits Olfr585 by modulating AKT-mediated processes, altering cellular events crucial for olfactory signal transduction. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
c-Jun N-terminal kinase (JNK) inhibitor influencing stress-related signaling. Its impact on JNK pathways indirectly inhibits Olfr585, disrupting cellular responses associated with stress signaling in the olfactory system. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
Akt inhibitor targeting the PI3K/AKT signaling pathway. Indirectly inhibits Olfr585 by modulating AKT-mediated processes, altering cellular events essential for olfactory signal transduction. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
NF-κB inhibitor impacting the NF-κB signaling pathway. Its modulation of this pathway indirectly inhibits Olfr585 by disrupting downstream processes crucial for olfactory signal transduction. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
Akt kinase inhibitor affecting the PI3K/AKT signaling pathway. Indirectly inhibits Olfr585 by modulating AKT-mediated processes, altering cellular events crucial for olfactory signal transduction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Phosphoinositide 3-kinase (PI3K) inhibitor affecting the PI3K/AKT signaling pathway. Indirectly inhibits Olfr585 by disrupting downstream processes crucial for olfactory signal transduction. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 mitogen-activated protein kinase (MAPK) inhibitor disrupting inflammatory signaling pathways. Its impact on MAPK cascades indirectly inhibits Olfr585, as the receptor is sensitive to alterations in inflammatory signals in the olfactory system. | ||||||